Concert Pharmaceuticals, Inc. Total Liabilities
Concert Pharmaceuticals, Inc. had Total Liabilities of $37.86 million as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2022-11-07
- 2022-09-30: Liabilities $37.86M.
- 2022-06-30: Liabilities $48.60M.
- 2022-03-31: Liabilities $52.84M.
- 2021-12-31: Liabilities $53.09M.
| Period end | Liabilities |
|---|---|
| 2022-09-30 | $37.86M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $48.60M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $52.84M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $53.09M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $29.05M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $25.99M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $25.95M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $28.10M 10-K · filed 2022-03-03 |
| 2020-09-30 | $25.43M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $27.91M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $32.80M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $36.01M 10-K · filed 2021-02-25 |
| 2019-09-30 | $32.69M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $32.90M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $33.59M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $24.81M 10-K · filed 2020-02-27 |
| 2018-09-30 | $22.80M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $20.23M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $17.25M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $15.30M 10-K · filed 2019-02-28 |
| 2017-09-30 | $16.37M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $44.24M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $14.01M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $14.80M 10-K · filed 2018-03-01 |
| 2016-09-30 | $16.22M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $16.45M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $15.03M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $16.30M 10-K · filed 2017-03-06 |
| 2015-09-30 | $17.39M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $20.46M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $24.87M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $29.63M 10-K · filed 2016-03-01 |
| 2014-09-30 | $32.73M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $34.00M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $36.43M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $39.63M 10-K · filed 2015-03-02 |